Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

7 of 7 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

Phase 2
9(100.0%)
9Total
Phase 2(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT04297683Phase 2Recruiting

HEALEY ALS Platform Trial - Master Protocol

Role: lead

NCT07410806Phase 2Enrolling By Invitation

HEALEY ALS Platform Trial - Regimen I NUZ-001

Role: lead

NCT05842941Phase 2Completed

HEALEY ALS Platform Trial - Regimen G DNL343

Role: lead

NCT05740813Phase 2Completed

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Role: lead

NCT05136885Phase 2Completed

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Role: lead

NCT04615923Phase 2Completed

HEALEY ALS Platform Trial - Regimen D Pridopidine

Role: lead

NCT04414345Phase 2Completed

HEALEY ALS Platform Trial - Regimen C CNM-Au8

Role: lead

NCT04436497Phase 2Completed

HEALEY ALS Platform Trial - Regimen A Zilucoplan

Role: lead

NCT04436510Phase 2Completed

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Role: lead

All 9 trials loaded